Log in
NASDAQ:UTHR

United Therapeutics Short Interest Ratio and Short Volume

$135.54
+0.47 (+0.35 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$134.29
Now: $135.54
$135.86
50-Day Range
$104.01
MA: $127.99
$142.93
52-Week Range
$75.58
Now: $135.54
$144.26
Volume113,254 shs
Average Volume509,672 shs
Market Capitalization$6.02 billion
P/E Ratio13.92
Dividend YieldN/A
Beta0.71

Short Interest

United Therapeutics (NASDAQ:UTHR) Short Interest Data

Current Short Volume:2,520,000 shares
Previous Short Volume:2,240,000 shares
Change Vs. Previous Month:+12.50%
Dollar Volume Sold Short:$356.53 million
Short Interest Ratio / Days to Cover:7.0
Last Record Date:October, 30 2020
Outstanding Shares:43,850,000 shares
Float Size:43,320,000 shares
Short Percent of Float:5.82%
Today's Trading Volume:113,254 shares
Average Trading Volume:509,672 shares
Today's Volume Vs. Average:-77.78%



United Therapeutics (NASDAQ:UTHR) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
10/30/20202,520,000 $356.53 million 12.5%5.8%6.8$141.48
10/15/20202,240,000 $276.42 million 9.8%5.2%6.9$123.40
9/30/20202,040,000 $220.97 million 10.9%4.7%7$108.32
9/15/20201,840,000 $184.83 million 0.0%4.3%5.4$100.45
8/31/20201,840,000 $188.89 million 10.8%4.3%4.7$102.66
8/14/20201,660,000 $175.15 million -0.6%3.8%3.7$105.51
7/31/20201,670,000 $185.07 million -13.5%3.9%3.2$110.82
7/15/20201,930,000 $215.14 million -17.2%4.6%3.2$111.47
6/30/20202,330,000 $261.57 million -26.5%5.5%3.7$112.26
6/15/20203,170,000 $385.31 million -1.9%7.5%4.9$121.55
5/29/20203,230,000 $391.73 million 5.6%7.6%4.6$121.28
5/15/20203,060,000 $360.93 million -14.0%7.2%4.2$117.95
4/30/20203,560,000 $415.84 million 16.3%8.4%5.1$116.81
4/15/20203,060,000 $353.92 million 7.4%7.2%4.6$115.66
3/31/20202,850,000 $316.95 million -10.0%6.7%4.5$111.21
3/13/20203,165,100 $303.44 million 37.6%7.5%4.6$95.87
2/28/20202,300,000 $193.09 million 8.0%5.4%4.6$83.95
2/14/20202,130,000 $214.04 million -10.5%5.0%4.7$100.49
1/31/20202,380,000 $251.83 million 12.3%5.6%5.8$105.81
1/15/20202,120,000 $214.44 million -2.8%5.0%5.1$101.15
12/31/20192,180,000 $194.74 million 0.5%5.2%5.4$89.33

United Therapeutics (NASDAQ:UTHR) Short Interest FAQ

speech bubbles
speech bubbles











What is United Therapeutics' current short interest?

Short interest is the volume of United Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 30th, investors have sold 2,520,000 shares of UTHR short. 5.82% of United Therapeutics' shares are currently sold short. View details.

What is a good short interest ratio for United Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. United Therapeutics currently has a short interest ratio of 7.0.

What is a good short interest percentage for United Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.82% of United Therapeutics' floating shares are currently sold short.

Is United Therapeutics' short interest increasing or decreasing?

United Therapeutics saw a increase in short interest during the month of October. As of October 30th, there was short interest totaling 2,520,000 shares, an increase of 12.5% from the previous total of 2,240,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is United Therapeutics' float size?

United Therapeutics currently has issued a total of 44,441,000 shares. Some of United Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. United Therapeutics currently has a public float of 43,320,000 shares.

How does United Therapeutics' short interest compare to its competitors?

5.82% of United Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "biotechnology" compare to United Therapeutics: Amgen Inc. (1.22%), Gilead Sciences, Inc. (1.82%), Vertex Pharmaceuticals Incorporated (0.00%), Regeneron Pharmaceuticals, Inc. (2.13%), Biogen Inc. (2.47%), Seagen Inc. (0.00%), Alexion Pharmaceuticals, Inc. (1.94%), Incyte Co. (0.00%), Exact Sciences Co. (0.00%), and Alnylam Pharmaceuticals, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.66 billion), Aon Plc ($3.83 billion), Analog Devices, Inc. ($3.33 billion), ViacomCBS Inc. ($3.13 billion), Snap Inc. ($3.05 billion), The Clorox Company ($2.85 billion), Uber Technologies, Inc. ($2.80 billion), Moderna, Inc. ($2.26 billion), Simon Property Group, Inc. ($2.02 billion), and International Flavors & Fragrances Inc. ($1.96 billion). View all of the most shorted stocks.

What does it mean to sell short United Therapeutics stock?

Short selling UTHR is an investing strategy that aims to generate trading profit from United Therapeutics as its price is falling. United Therapeutics' stock is trading up $0.47 today. To short United Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that United Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against United Therapeutics?

A short squeeze for United Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of UTHR, which in turn drives the price of the stock up even further.

How often is United Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UTHR, twice per month. The most recent reporting period available is October, 30 2020.


This page was last updated on 11/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.